Webinar FAQ: Advance Biopharma Tech Transfer Using Process Modeling and Simulation
This FAQ document shares answers to questions from the webinar, “Advance Biopharma Tech Transfer Using Process Modeling and Simulation.”
Questions include:
- Does Aspen Plus® leverage bioreactor kinetic models?
- Does AspenTech have any use cases for small molecule manufacturing simulators?
- What AspenTech products are typically used for computational modeling and simulation (CM&S) in biopharma?
- From a regulatory standpoint what has been the reception to including models in the filing, from your experience?
Read the FAQ to learn more.
Related Content
While biotherapeutics is one of the fastest growing sectors in life sciences today, the tech transfer process still takes many years. Regulatory approval can be time consuming—from conducting clinical trials to achieving a validated process design.
Video:
Advance Data-Driven Biopharma Decisions with a Robust, Integrated Digital Strategy
Report:
The Needle is Moving: Digital Transformation in Life-Sciences Manufacturing
Report:
Seizing New Opportunities: Pharma’s Roadmap for Smarter Manufacturing